The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

“The biggest risk for lung cancer is cigarette smoking,” says Waqar. It’s estimated that 85% of lung cancer deaths are ...

Early detection of lung cancer can drastically improve survival rates. Sponsored by Virginia Mason Franciscan Health.

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

STATEWIDE -- Maine has a higher lung cancer rate than the national average. Amy McClary, a patient navigator in the cancer ...

New research is raising concerns this Lung Cancer Awareness Month, showing an increase in lung cancer diagnoses among younger ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...